{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "34045463",
  "DateCompleted": {
    "Year": "2021",
    "Month": "06",
    "Day": "09"
  },
  "DateRevised": {
    "Year": "2023",
    "Month": "02",
    "Day": "02"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2021",
        "Month": "05",
        "Day": "27"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "3199",
      "10.1038/s41467-021-23394-4"
    ],
    "Journal": {
      "ISSN": "2041-1723",
      "JournalIssue": {
        "Volume": "12",
        "Issue": "1",
        "PubDate": {
          "Year": "2021",
          "Month": "May",
          "Day": "27"
        }
      },
      "Title": "Nature communications",
      "ISOAbbreviation": "Nat Commun"
    },
    "ArticleTitle": "Cell-free DNA captures tumor heterogeneity and driver alterations in rapid autopsies with pre-treated metastatic cancer.",
    "Pagination": {
      "StartPage": "3199",
      "MedlinePgn": "3199"
    },
    "Abstract": {
      "AbstractText": [
        "In patients with metastatic cancer, spatial heterogeneity of somatic alterations may lead to incomplete assessment of a cancer's mutational profile when analyzing a single tumor biopsy. In this study, we perform sequencing of cell-free DNA (cfDNA) and distinct metastatic tissue samples from ten rapid autopsy cases with pre-treated metastatic cancer. We show that levels of heterogeneity in genetic biomarkers vary between patients but that gene expression signatures representative of the tumor microenvironment are more consistent. Across nine patients with plasma samples available, we are able to detect 62/62 truncal and 47/121 non-truncal point mutations in cfDNA. We observe that mutation clonality in cfDNA is correlated with the number of metastatic lesions in which the mutation is detected and use this result to derive a clonality threshold to classify truncal and non-truncal driver alterations with reasonable specificity. In contrast, mutation truncality is more often incorrectly assigned when studying single tissue samples. Our results demonstrate the utility of a single cfDNA sample relative to that of single tissue samples when treating patients with metastatic cancer."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Novartis Institutes for Biomedical Research, Cambridge, MA, USA."
          }
        ],
        "LastName": "Pereira",
        "ForeName": "Bernard",
        "Initials": "B"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Massachusetts General Hospital Cancer Center, Department of Medicine, Harvard Medical School, Boston, MA, USA."
          }
        ],
        "LastName": "Chen",
        "ForeName": "Christopher T",
        "Initials": "CT"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Massachusetts General Hospital Cancer Center, Department of Medicine, Harvard Medical School, Boston, MA, USA."
          }
        ],
        "LastName": "Goyal",
        "ForeName": "Lipika",
        "Initials": "L"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Massachusetts General Hospital Cancer Center, Department of Medicine, Harvard Medical School, Boston, MA, USA."
          }
        ],
        "LastName": "Walmsley",
        "ForeName": "Charlotte",
        "Initials": "C"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Massachusetts General Hospital Cancer Center, Department of Medicine, Harvard Medical School, Boston, MA, USA."
          }
        ],
        "LastName": "Pinto",
        "ForeName": "Christopher J",
        "Initials": "CJ"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Massachusetts General Hospital Cancer Center, Department of Medicine, Harvard Medical School, Boston, MA, USA."
          }
        ],
        "LastName": "Baiev",
        "ForeName": "Islam",
        "Initials": "I"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Massachusetts General Hospital Cancer Center, Department of Medicine, Harvard Medical School, Boston, MA, USA."
          }
        ],
        "LastName": "Allen",
        "ForeName": "Read",
        "Initials": "R"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Massachusetts General Hospital Cancer Center, Department of Medicine, Harvard Medical School, Boston, MA, USA."
          }
        ],
        "LastName": "Henderson",
        "ForeName": "Laura",
        "Initials": "L"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Massachusetts General Hospital Cancer Center, Department of Medicine, Harvard Medical School, Boston, MA, USA."
          }
        ],
        "LastName": "Saha",
        "ForeName": "Supriya",
        "Initials": "S"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Massachusetts General Hospital Cancer Center, Department of Medicine, Harvard Medical School, Boston, MA, USA."
          }
        ],
        "LastName": "Reyes",
        "ForeName": "Stephanie",
        "Initials": "S"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Pathology, Massachusetts General Hospital, Boston, MA, USA."
          }
        ],
        "LastName": "Taylor",
        "ForeName": "Martin S",
        "Initials": "MS"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Massachusetts General Hospital Cancer Center, Department of Medicine, Harvard Medical School, Boston, MA, USA."
          }
        ],
        "LastName": "Fitzgerald",
        "ForeName": "Donna M",
        "Initials": "DM"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Massachusetts General Hospital Cancer Center, Department of Medicine, Harvard Medical School, Boston, MA, USA."
          }
        ],
        "LastName": "Broudo",
        "ForeName": "Maida Williams",
        "Initials": "MW"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Massachusetts General Hospital Cancer Center, Department of Medicine, Harvard Medical School, Boston, MA, USA."
          }
        ],
        "LastName": "Sahu",
        "ForeName": "Avinash",
        "Initials": "A"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Massachusetts General Hospital Cancer Center, Department of Medicine, Harvard Medical School, Boston, MA, USA."
          }
        ],
        "LastName": "Gao",
        "ForeName": "Xin",
        "Initials": "X"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Novartis Institutes for Biomedical Research, Cambridge, MA, USA."
          }
        ],
        "LastName": "Winckler",
        "ForeName": "Wendy",
        "Initials": "W"
      },
      {
        "Identifier": [
          "0000-0003-4610-0149"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Novartis Institutes for Biomedical Research, Cambridge, MA, USA."
          }
        ],
        "LastName": "Brannon",
        "ForeName": "A Rose",
        "Initials": "AR"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Novartis Institutes for Biomedical Research, Cambridge, MA, USA."
          }
        ],
        "LastName": "Engelman",
        "ForeName": "Jeffrey A",
        "Initials": "JA"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Novartis Institutes for Biomedical Research, Cambridge, MA, USA."
          }
        ],
        "LastName": "Leary",
        "ForeName": "Rebecca",
        "Initials": "R"
      },
      {
        "Identifier": [
          "0000-0001-9122-3311"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Pathology, Massachusetts General Hospital, Boston, MA, USA."
          }
        ],
        "LastName": "Stone",
        "ForeName": "James R",
        "Initials": "JR"
      },
      {
        "Identifier": [
          "0000-0002-3863-9841"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Novartis Institutes for Biomedical Research, Cambridge, MA, USA. Katie.Campbell@novartis.com."
          }
        ],
        "LastName": "Campbell",
        "ForeName": "Catarina D",
        "Initials": "CD"
      },
      {
        "Identifier": [
          "0000-0003-2983-7704"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Massachusetts General Hospital Cancer Center, Department of Medicine, Harvard Medical School, Boston, MA, USA. Juric.Dejan@mgh.harvard.edu."
          }
        ],
        "LastName": "Juric",
        "ForeName": "Dejan",
        "Initials": "D"
      }
    ],
    "GrantList": [
      {
        "GrantID": "K99 CA248953",
        "Acronym": "CA",
        "Agency": "NCI NIH HHS",
        "Country": "United States"
      }
    ],
    "PublicationTypeList": [
      "Evaluation Study",
      "Journal Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "England",
    "MedlineTA": "Nat Commun",
    "NlmUniqueID": "101528555",
    "ISSNLinking": "2041-1723"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Biomarkers, Tumor"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Circulating Tumor DNA"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Antineoplastic Combined Chemotherapy Protocols"
    },
    {
      "QualifierName": [
        "methods"
      ],
      "DescriptorName": "Autopsy"
    },
    {
      "QualifierName": [
        "genetics"
      ],
      "DescriptorName": "Biomarkers, Tumor"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Chemoradiotherapy, Adjuvant"
    },
    {
      "QualifierName": [
        "genetics"
      ],
      "DescriptorName": "Circulating Tumor DNA"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Cohort Studies"
    },
    {
      "QualifierName": [],
      "DescriptorName": "DNA Copy Number Variations"
    },
    {
      "QualifierName": [
        "methods"
      ],
      "DescriptorName": "DNA Mutational Analysis"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Female"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Genetic Heterogeneity"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Male"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Neoadjuvant Therapy"
    },
    {
      "QualifierName": [
        "blood",
        "diagnosis",
        "pathology",
        "therapy"
      ],
      "DescriptorName": "Neoplasms"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Point Mutation"
    },
    {
      "QualifierName": [],
      "DescriptorName": "RNA-Seq"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Reference Values"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Sensitivity and Specificity"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Spatial Analysis"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Time Factors"
    },
    {
      "QualifierName": [
        "genetics"
      ],
      "DescriptorName": "Tumor Microenvironment"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Exome Sequencing"
    }
  ],
  "CoiStatement": "B.P., C.D.C., R.L., and J.E. are employees of Novartis. W.W. and A.R.B. are former Novartis employees. C.D.C. and W.W. own Novartis shares. C.T.C. is a consultant for Blackstone Life Sciences, Foundation Medicine, and HotSpot Therapeutics. L.G. has received funding from AstraZeneca, scientific advisory board fees\u00a0from Agios Pharmaceuticals, Inc., Alentis Therapeutics AG, H3 Biomedicine, Incyte Corporation, QED Therapeutics, Sirtex Medical Ltd., Taiho Oncology Inc. DSMC, and\u00a0institutional research\u00a0funds from Agios, Adaptimmune, Bayer, Eisai, Merck, Macrogenics, Genentech, Novartis, Incyte, Eli Lilly, Loxo Oncology, Relay Therapeutics, QED, Taiho Oncology, Leap Therapeutics, Bristol Meyers Squibb, and Nucana. D.J. has received scientific advisory board fees from Eisai, EMD Serano, Genentech, Ipsen, Novartis, Guardant Health, Syros, MapKure, Vibliome Therapeutics, and Relay Therapeutics, and institutional research funds from Novartis, Genentech, EMD Serano, Eisai, Takeda, Pfizer, Seagen, Ribon Therapeutics, Infinity Pharamaceuticals, InventisBio, Arvinas, and Amgen.\u00a0All other authors declare no competing interests."
}